2013 Catecholamines Gordon Research Conference and Gordon Research Seminar
2013年儿茶酚胺戈登研究会议暨戈登研究研讨会
基本信息
- 批准号:8593885
- 负责人:
- 金额:$ 2.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-15 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAnimal Disease ModelsAttention deficit hyperactivity disorderBehaviorBehavioralBipolar DisorderCardiovascular DiseasesCatecholaminesCognitionDecision MakingDevelopmentDisciplineDiseaseDopamineDrug AddictionEconomicsEnsureEpinephrineEquilibriumEvaluationFertilizationFosteringFunctional disorderFundingFuture GenerationsGenderGoalsHumanLeadLengthMental DepressionMinorityMolecularMood DisordersMoodsMotorNeuraxisNeurobiologyNeurologicNeuronsNorepinephrineParkinson DiseaseParticipantPeripheralPhysiologyPlayPostdoctoral FellowRegulationResearchResearch PersonnelResortRewardsRoleSchizophreniaScientistSnowSourceStressStructureSubstance abuse problemSynapsesSystemTechniquesVermontWomanaddictionbasegraduate studenthuman diseaseinnovationmeetingsnervous system disorderneuropsychiatrynovelplanetary Atmosphereprogramspsychologicpublic health relevancereceptorresponsesymposiumtransmission process
项目摘要
DESCRIPTION (provided by applicant): The 2013 GRC/GRS Seminar on Catecholamines will take place at Mount Snow Resort, in West Dover, Vermont. August 10 - 16, 2013. This conference is held every other year; it is an ideal forum for exploring new developments in the field of catecholamines. It is also an excellent opportunity for junior investigators and trainees o interact with established investigators in a relaxed atmosphere. The evaluations of recent conferences highlight the strong impact this meeting typically has on emerging as well as established scientists. As the funds allocated by the Gordon Conference organization are limited, we are requesting funding from other sources. We are hoping that the results of our requests enable us to support speakers and discussion leaders as well as a large number of junior investigators to participate in the meeting. The conference includes two plenary talks, by Dr. Roy Wise and Dr. Susan Sesack. The preliminary program includes a large number of junior scientists and women, and the sessions planned include: 1) Catecholamines and Stress, 2) Catecholamines and Neurological Disorders, 3) Catecholamines in Substance Abuse, 4) Synaptic Regulation of Catecholaminergic Transmission, 5) Catecholamines Receptors, 6) Circuit-level Regulation of Catecholamine Function, 7) Economic Decision Making, 8) Catecholamines and Cognition and 9) Catecholamines Transporters. The themes covered in the 2013 Gordon Conference on Catecholamines are highly relevant to understanding the neurobiological bases of drug addiction and a variety of neurological and neuropsychiatric disorders including schizophrenia, affective disorders, bipolar disorder, OCD, and Parkinson's disease. This forum will provide a unique opportunity to discuss recent advances in the understanding of how catecholamine systems may contribute to the pathophysiology and treatment of those conditions. The fact that a large proportion of the participants are junior investigators and a significant number will be graduate students and postdocs ensure that this conference may have an impact on how future generations of neuroscientists view these issues.
描述(由申请人提供):2013年GRC/GRS Catecholamines研讨会将在佛蒙特州西多佛的Mount Snow Resort举行。 2013年8月10日至16日。一次会议每隔一年举行;它是探索儿茶酚胺领域的新发展的理想论坛。对于初级调查人员和学员来说,这也是一个很好的机会,o在轻松的氛围中与已建立的研究人员互动。对最近的会议的评估凸显了这次会议通常对新兴和既定科学家的强烈影响。由于戈登会议组织分配的资金有限,我们要求其他来源的资金。我们希望我们的请求结果使我们能够支持演讲者和讨论负责人以及大量的初级调查人员参加会议。会议包括罗伊·怀斯(Roy Wise)博士和苏珊·塞萨克(Susan Sesack)博士的两次全体会谈。 The preliminary program includes a large number of junior scientists and women, and the sessions planned include: 1) Catecholamines and Stress, 2) Catecholamines and Neurological Disorders, 3) Catecholamines in Substance Abuse, 4) Synaptic Regulation of Catecholaminergic Transmission, 5) Catecholamines Receptors, 6) Circuit-level Regulation of Catecholamine Function, 7) Economic Decision Making, 8)儿茶酚胺和认知以及9)儿茶酚胺转运蛋白。 2013年戈登儿茶酚胺会议上涵盖的主题与了解药物成瘾的神经生物学基础高度相关,以及包括精神分裂症,情感障碍,双皮亚障碍,OCD和帕金森氏病在内的各种神经和神经精神疾病。该论坛将提供一个独特的机会,讨论了解儿茶酚胺系统如何有助于这些疾病的病理生理学和治疗的最新进展。很大一部分参与者是初级调查人员,并且有很大一部分是研究生和博士后,确保本次会议可能会影响到子孙后代的神经科学家如何看待这些问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul E. M. Phillips其他文献
Paul E. M. Phillips的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul E. M. Phillips', 18)}}的其他基金
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10215470 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10399567 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10612394 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Neural mechanisms regulating cocaine consumption
调节可卡因消耗的神经机制
- 批准号:
10035032 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking
在吸毒和寻求药物调节中,阶段性多巴胺对偶然和非偶然药物线索的直径变化
- 批准号:
9230365 - 财政年份:2015
- 资助金额:
$ 2.52万 - 项目类别:
8/8 NADIA UO1 Adolescent Alcohol and Decision Making
8/8 NADIA UO1 青少年酒精与决策
- 批准号:
9762555 - 财政年份:2015
- 资助金额:
$ 2.52万 - 项目类别:
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking
在吸毒和寻求药物调节中,阶段性多巴胺对偶然和非偶然药物线索的直径变化
- 批准号:
8912638 - 财政年份:2015
- 资助金额:
$ 2.52万 - 项目类别:
Contribution of dopamine to risk attitude across the lifespan
多巴胺对整个生命周期风险态度的贡献
- 批准号:
8413188 - 财政年份:2012
- 资助金额:
$ 2.52万 - 项目类别:
Contribution of dopamine to risk attitude across the lifespan
多巴胺对整个生命周期风险态度的贡献
- 批准号:
8733509 - 财政年份:2012
- 资助金额:
$ 2.52万 - 项目类别:
Contribution of dopamine to risk attitude across the lifespan
多巴胺对整个生命周期风险态度的贡献
- 批准号:
8549099 - 财政年份:2012
- 资助金额:
$ 2.52万 - 项目类别:
相似国自然基金
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
冠状动脉微血管疾病大动物模型中关键分子和心肌血流超声显像新技术研究
- 批准号:
- 批准年份:2020
- 资助金额:297 万元
- 项目类别:重点项目
视神经脊髓炎谱系疾病非人灵长类动物模型构建及表型评价
- 批准号:82071341
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
mTOR信号通路在耳蜗毛细胞发育和存活中的调控作用及其机制研究
- 批准号:81900937
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
糖脂代谢紊乱疾病灵长类动物模型构建与DNA/RNA编辑介导的基因治疗方法开发
- 批准号:91957122
- 批准年份:2019
- 资助金额:82.0 万元
- 项目类别:重大研究计划
相似海外基金
Effects of acetaminophen on prenatal brain development: an organoid model
对乙酰氨基酚对产前大脑发育的影响:类器官模型
- 批准号:
10510873 - 财政年份:2022
- 资助金额:
$ 2.52万 - 项目类别:
Developmental Origins of Neurotoxicity of the PFAS GenX
X 代 PFAS 神经毒性的发育起源
- 批准号:
10392474 - 财政年份:2021
- 资助金额:
$ 2.52万 - 项目类别:
Developmental Origins of Neurotoxicity of the PFAS GenX
X 代 PFAS 神经毒性的发育起源
- 批准号:
10218403 - 财政年份:2021
- 资助金额:
$ 2.52万 - 项目类别:
Maternal Control Over Developing Prefrontal Cortex and Transition in Independence
母亲对前额皮质发育和独立过渡的控制
- 批准号:
10728676 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别: